Evolution in the influenza A H3 stalk - A challenge for broad-spectrum vaccines?

Journal of General Virology

Volumn 95, Issue PART 2, 2014, Pages 317-324

  Lees, William D ^a   Moss, David S ^a   Shepherd, Adrian J ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONSENSUS SEQUENCE; GLYCOSYLATION; HUMAN; INFLUENZA A; INFLUENZA VIRUS A H3N2; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; VIRUS MUTATION;

ANTIBODIES, VIRAL; COMPUTATIONAL BIOLOGY; EPITOPES, B-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENETIC VARIATION; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; SEQUENCE ANALYSIS, DNA;

EID: 84892571101     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.059410-0     Document Type: Article

References (39)

1. Burioni, R., Canducci, F., Mancini, N., Clementi, N., Sassi, M., De Marco, D., Saita, D., Diotti, R. A., Sautto, G. & other authors (2009). Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV). New Microbiol 32, 319-324.
2. Bush, R. M., Fitch, W. M., Bender, C. A. & Cox, N. J. (1999). Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 16, 1457-1465.
3. Clementi, N., De Marco, D., Mancini, N., Solforosi, L., Moreno, G. J., Gubareva, L. V., Mishin, V., Di Pietro, A., Vicenzi, E. & other authors (2011). A human monoclonal antibody with neutralizing activity against highly divergent influenza subtypes. PLoS ONE 6, e28001.
4. Corti, D., Voss, J., Gamblin, S. J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S. G., Pinna, D., Minola, A. & other authors (2011). A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850-856.
5. DeMarco, D., Clementi, N., Mancini, N., Solforosi, L., Moreno, G. J., Sun, X., Tumpey, T. M., Gubareva, L. V., Mishin, V. & other authors (2012). A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses. PLoS ONE 7, e34415.
6. Dreyfus, C., Laursen, N. S., Kwaks, T., Zuijdgeest, D., Khayat, R., Ekiert, D. C., Lee, J. H., Metlagel, Z., Bujny, M. V. & other authors (2012). Highly conserved protective epitopes on influenza B viruses. Science 337, 1343-1348.
7. Ekiert, D. C. & Wilson, I. A. (2012). Broadly neutralizing antibodies against influenza virus and prospects for universal therapies. Curr Opin Virol 2, 134-141.
8. Ekiert, D. C., Bhabha, G., Elsliger, M.-A., Friesen, R. H. E., Jongeneelen, M., Throsby, M., Goudsmit, J. & Wilson, I. A. (2009). Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246-251.
9. Ekiert, D. C., Friesen, R. H. E., Bhabha, G., Kwaks, T., Jongeneelen, M., Yu, W., Ophorst, C., Cox, F., Korse, H. J. W. M. & other authors (2011). A highly conserved neutralizing epitope on group 2 influenza A viruses. Science 333, 843-850.
10. Fleury, D., Barrère, B., Bizebard, T., Daniels, R. S., Skehel, J. J. & Knossow, M. (1999). A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site. Nat Struct Biol 6, 530-534.
11. Gallagher, P., Henneberry, J., Wilson, I., Sambrook, J. & Gething, M. J. (1988). Addition of carbohydrate side chains at novel sites on influenza virus hemagglutinin can modulate the folding, transport, and activity of the molecule. J Cell Biol 107, 2059-2073.
12. Hashem, A. M., Van Domselaar, G., Li, C., Wang, J., She, Y.-M., Cyr, T. D., Sui, J., He, R., Marasco, W. A. & Li, X. (2010). Universal antibodies against the highly conserved influenza fusion peptide cross-neutralize several subtypes of influenza A virus. Biochem Biophys Res Commun 403, 247-251.
13. Kringelum, J. V., Nielsen, M., Padkjær, S. B. & Lund, O. (2013). Structural analysis of B-cell epitopes in antibody: protein complexes. Mol Immunol 53, 24-34.
14. Laskowski, R. A. (2009). PDBsum new things. Nucleic Acids Res 37 (Database issue), D355-D359.
15. Lees, W. D., Moss, D. S. & Shepherd, A. J. (2011). Analysis of antigenically important residues in human influenza A virus in terms of B-cell epitopes. J Virol 85, 8548-8555.
16. Martínez-Sobrido, L., Cadagan, R., Steel, J., Basler, C. F., Palese, P., Moran, T. M. & García-Sastre, A. (2010). Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol 84, 2157-2163.
17. Maurer-Stroh, S., Lee, R. T. C., Eisenhaber, F., Cui, L., Phuah, S. P. & Lin, R. T. (2010). A new common mutation in the hemagglutinin of the 2009 (H1N1) influenza A virus. PLoS Curr 2, RRN1162.
18. Okuno, Y., Isegawa, Y., Sasao, F. & Ueda, S. (1993). A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J Virol 67, 2552-2558.
19. Pica, N., Hai, R., Krammer, F., Wang, T. T., Maamary, J., Eggink, D., Tan, G. S., Krause, J. C., Moran, T. & other authors (2012). Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses. Proc Natl Acad Sci U S A 109, 2573-2578.
20. Rubinstein, N. D., Mayrose, I., Halperin, D., Yekutieli, D., Gershoni, J. M. & Pupko, T. (2008). Computational characterization of B-cell epitopes. Mol Immunol 45, 3477-3489.
21. Russ, G., Poláková, K., Kostolanský, F., Styk, B. & Vancíková, M. (1987). Monoclonal antibodies to glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. Acta Virol 31, 374-386.
22. Russell, R. J., Gamblin, S. J., Haire, L. F., Stevens, D. J., Xiao, B., Ha, Y. & Skehel, J. J. (2004). H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325, 287-296.
23. Schmeisser, F., Friedman, R., Besho, J., Lugovtsev, V., Soto, J., Wang, W., Weiss, C., Williams, O., Xie, H. & other authors (2013). Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin. Influenza Other Respi Viruses 7, 480-490.
24. Shih, A. C.-C., Hsiao, T.-C., Ho, M.-S. & Li, W.-H. (2007). Simultaneous amino acid substitutions at antigenic sites drive influenza A hemagglutinin evolution. Proc Natl Acad Sci U S A 104, 6283-6288.
25. Skehel, J. J., Stevens, D. J., Daniels, R. S., Douglas, A. R., Knossow, M., Wilson, I. A. & Wiley, D. C. (1984). A carbohydrate side chain on hemagglutinins of Hong Kong influenza viruses inhibits recognition by a monoclonal antibody. Proc Natl Acad Sci U S A 81, 1779-1783.
26. Staneková, Z., Mucha, V., Sládková, T., Blaškovičová, H., Kostolanský, F. & Varečková, E. (2012). Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection. Influenza Other Respi Viruses 6, 389-395.
27. Strengell, M., Ikonen, N., Ziegler, T. & Julkunen, I. (2011). Minor changes in the hemagglutinin of influenza A (H1N1) 2009 virus alter its antigenic properties. PLoS ONE 6, e25848.
28. Sui, J., Hwang, W. C., Perez, S., Wei, G., Aird, D., Chen, L. M., Santelli, E., Stec, B., Cadwell, G. & other authors (2009). Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 16, 265-273.
29. Tang, J. W., Ngai, K. L. K., Lam, W. Y. & Chan, P. K. S. (2008). Seasonality of influenza A (H3N2) virus: a Hong Kong perspective (1997-2006). PLoS ONE 3, e2768.
30. + memory B cells. PLoS ONE 3, e3942.
31. Tsibane, T., Ekiert, D. C., Krause, J. C., Martinez, O., Crowe, J. E., Jr, Wilson, I. A. & Basler, C. F. (2012). Influenza human monoclonal antibody 1F1 interacts with three major antigenic sites and residues mediating human receptor specificity in H1N1 viruses. PLoS Pathog 8, e1003067.
32. Wang, T. T. & Palese, P. (2009). Universal epitopes of influenza virus hemagglutinins? Nat Struct Mol Biol 16, 233-234.
33. Wang, W., Anderson, C. M., De Feo, C. J., Zhuang, M., Yang, H., Vassell, R., Xie, H., Ye, Z., Scott, D. & Weiss, C. D. (2011). Crossneutralizing antibodies to pandemic 2009 H1N1 and recent seasonal H1N1 influenza A strains influenced by a mutation in hemagglutinin subunit 2. PLoS Pathog 7, e1002081.
34. WHO (2009). Influenza WHO Fact Sheet No 211. http: //www. who. int/mediacentre/factsheets/fs211/en/. World Health Organization
35. Wiley, D. C. & Skehel, J. J. (1987). The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu Rev Biochem 56, 365-394.
36. Wiley, D. C., Wilson, I. A. & Skehel, J. J. (1981). Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289, 373-378.
37. Wilson, I. A. & Cox, N. J. (1990). Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8, 737-787.
38. Wilson, I. A., Skehel, J. J. & Wiley, D. C. (1981). Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Åresolution. Nature 289, 366-373.
39. Wrammert, J., Koutsonanos, D., Li, G.-M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M. & other authors (2011). Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J Exp Med 208, 181-193.